Results 221 to 230 of about 2,590,210 (272)
Some of the next articles are maybe not open access.
Technical aspects of cytoreductive surgery
Journal of Surgical Oncology, 2008AbstractAt the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2 ...
Shigeki, Kusamura +4 more
openaire +2 more sources
Patient Selection for Cytoreductive Surgery
Surgical Oncology Clinics of North America, 2018The peritoneal malignancies span the biologic spectrum of aggressiveness from the indolent growth pattern and superficial nature of well-differentiated mucinous appendiceal adenocarcinoma to the rapidly growing and invasive nature of poorly differentiated signet ring cell adenocarcinomas of the appendix, colon, and stomach.
Travis E, Grotz +2 more
openaire +2 more sources
Cytoreductive surgery for ovarian cancer
European Journal of Surgical Oncology (EJSO), 2003The aim of this study is to describe the technique of managing peritoneal dissemination in patients with ovarian cancer, based on radical surgical excision and, later, perioperative chemotherapy.Treatments included complete surgical resection of the peritoneal disease, and intraperitoneal intraoperative and postoperative chemotherapy, using Adriamycin ...
D M, Kecmanovic +4 more
openaire +2 more sources
Surgery, gynecology & obstetrics, 1990
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
Annals of Surgical Oncology, 2021
Cascales Campos Pedro Antonio +10 more
semanticscholar +1 more source
Cascales Campos Pedro Antonio +10 more
semanticscholar +1 more source
SECONDARY CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
Obstetrics and Gynecology Clinics of North America, 1994Secondary cytoreduction to optimal levels can be successfully accomplished in a substantial number of ovarian cancer patients and in a variety of clinical settings. Although frequently complex, secondary operations can be performed with acceptable morbidity. All operations should be undertaken by experienced oncologic surgeons.
T W, Burke, M, Morris
openaire +2 more sources
Hepatic Cytoreductive Surgery for Neuroendocrine Cancer
Surgical Oncology Clinics of North America, 2007Patients with gut-based metastatic neuroendocrine tumors (NET) often present late in the course of their slowly progressive disease, when cancer has extended beyond the point of reasonable expectation for surgical cure. At this stage of disease, the tumor's overwhelming hormonal production often significantly impairs the patient's quality of life ...
Byron E, Wright +2 more
openaire +2 more sources
Cytoreductive surgery for recurrent ovarian cancer
Current Opinion in Obstetrics & Gynecology, 2007The issue facing clinicians managing ovarian cancer has evolved over the past three decades from treatment for cure and subsequently palliation, to prolongation of survival for most patients. The purpose of this paper is to review the data, rationale, and issues surrounding cytoreductive surgery in recurrent ovarian cancer and its potential role in ...
Jan, Hauspy, Allan, Covens
openaire +2 more sources
Advanced cytoreductive surgery: Asia Pacific perspective
Gynecologic Oncology, 2009The thoroughness of cytoreductive surgery is the largest contributor to survival for patients with advanced ovarian and primary peritoneal carcinoma. For many years the surgery undertaken by Gynaecologic Oncologists has been tailored to match their surgical training.
Crandon, Alexander J., Obermair, Andreas
openaire +3 more sources
[Cytoreductive surgery and immunotherapy].
Georgian medical news, 2007The aim of the article was to treat Pliss lymphosarcoma by means of Cytoreductive surgery to improve patient outcomes by taking into consideration the dynamics of Blood Auto-Proteolytic Activity (BAPA). In rats suffering from tumour proves to be obvious that higher the BAPA, more intensive is the process of invasive growth of tumour.
M D, Samsoniia +2 more
openaire +1 more source